+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Coagulation factor XII in thrombosis and inflammation



Coagulation factor XII in thrombosis and inflammation



Blood 131(17): 1903-1909



Combinations of proinflammatory and procoagulant reactions are the unifying principle for a variety of disorders affecting the cardiovascular system. The factor XII-driven contact system starts coagulation and inflammatory mechanisms via the intrinsic pathway of coagulation and the bradykinin-producing kallikrein-kinin system, respectively. The biochemistry of the contact system in vitro is well understood; however, its in vivo functions are just beginning to emerge. Challenging the concept of the coagulation balance, targeting factor XII or its activator polyphosphate, provides protection from thromboembolic diseases without interfering with hemostasis. This suggests that the polyphosphate/factor XII axis contributes to thrombus formation while being dispensable for hemostatic processes. In contrast to deficiency in factor XII providing safe thromboprotection, excessive FXII activity is associated with the life-threatening inflammatory disorder hereditary angioedema. The current review summarizes recent findings of the polyphosphate/factor XII-driven contact system at the intersection of procoagulant and proinflammatory disease states. Elucidating the contact system offers the exciting opportunity to develop strategies for safe interference with both thrombotic and inflammatory disorders.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055151639

Download citation: RISBibTeXText

PMID: 29483100

DOI: 10.1182/blood-2017-04-569111


Related references

Role of tissue factor in thrombosis. Coagulation-inflammation- thrombosis circuit. Frontiers in Bioscience 11: 256-271, 2006

Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit. Frontiers in Bioscience 11: 256-271, 2006

Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo. Journal of Clinical Investigation 99(10): 2446-2451, 1997

Coagulation factor VII. (Biochemistry, role in blood coagulation, methods of assay, congenital deficiencies and relationship with thrombosis). La Ricerca in Clinica e in Laboratorio 13(3): 287-298, 1983

Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. Frontiers in Bioscience 11: 59-80, 2006

Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. Frontiers in Bioscience 11: 59-80, 2006

Association of Coagulation Factors VIII/XI/XIII Polymorphisms With Coagulation Factor Activities and Deep Vein Thrombosis After Artificial Joints Replacement. American Journal of Therapeutics 23(6): E1547-E1553, 2016

No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats. Critical Care Medicine 34(10): 2646-2650, 2006

Inflammation, coagulation, vascular permeability and thrombosis. Current Vascular Pharmacology 10(5): 631, 2012

Tissue factor expression at the site of inflammation: a cross-talk between inflammation and the blood coagulation system. Rinsho Byori. Japanese Journal of Clinical Pathology 52(4): 342-349, 2004

High concentration of coagulation factor VIII as a risk factor for thrombosis. Nederlands Tijdschrift Voor Geneeskunde 145(46): 2213-2217, 2001

High levels of coagulation factor XI as a risk factor for venous thrombosis. New England Journal of Medicine 342(10): 696-701, 2000

Coagulation factor abnormalities following the Fontan procedure Factor VIII is increased and may predispose to thrombosis. Circulation 106(19 Suppl.): II-521, 2002

Determinants of increased levels of von Willebrand factor and coagulation factor VIII in patients with venous thrombosis. Netherlands Heart Journal 14(7-8): 277-278, 2006

A polymorphism nt 1628GfwdarwA in exon 10 of the coagulation factor V gene may be a risk factor for thrombosis in the indigenous thai population. Thrombosis & Haemostasis 80(4): 705-706, 1998